DRREDDY - IntraDay Trade Analysis with Live Signals
← Back to ListKey Parameters
⭐ IntraDay Trade Rating: 2.5
Show all parameters (20 more)
🧾 Trade Setup
I recommend a buy at 1,185 ₹ with an initial stop-loss order placed at 1,160 ₹, targeting a profit of 25₹ – 30₹. A secondary exit level should be set at 1,210 ₹ to secure gains if the stock breaks through this resistance level. Overall, while the volume is strong and the news is positive, the extreme valuation demands careful risk management, making this a moderately risky intraday trade.
✅ Positive
Immediate volume is very strong at 31.3M, significantly above the one-week average of 21.7M. The recent news regarding the Dengue shot deal provides a potential catalyst for continued buying interest today.
⚠️ Limitation
The extremely high P/E ratio of 148 relative to the industry’s PE of 34.8 indicates significant overvaluation, which presents a substantial risk if momentum stalls. Furthermore, the negative profit growth from the previous quarter (PAT Qtr: -219 Cr.) raises concerns about short-term sustainability and could trigger a sharp correction should the stock fail to maintain its upward trajectory.
🏭 Industry
The pharmaceutical sector is currently experiencing moderate volatility driven by regulatory changes and vaccine development opportunities, particularly in emerging markets. The Upstox report highlights potential upside for Dr. Reddy’s due to the exclusive agreement regarding the Dengue shot distribution, which could bolster investor confidence.